To identify putative malignant tumor cells present in primary BCC samples, we subjected the KRT14+ epithelial/tumor cells to InferCNV analysis (InferCNV of the Trinity CTAT Project; https://github.com/broadinstitute/inferCNV). The gene discussed is KRT14; the disease is neoplasm.